News
1h
Stocktwits on MSNNovavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval HopesNovavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...
Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5% ...
Canadian leaders made their final push for votes Sunday, one day before an election dominated by President Donald Trump's ...
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval commitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results